| BE0412-5MG
| InVivoMAb anti-human GPC3
| 5 mg
| BioXCell
| , ,
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0399-5MG
| InVivoMAb anti-mouse VEGF-A
| 5 mg
| BioXCell
| in vivo VEGF-A neutralization, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0036-100MG
| InVivoPlus anti-mouse NK1.1
| 100 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0083-25MG
| InVivoPlus mouse IgG1 isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0396-25MG
| InVivoMAb anti-human/mouse GRP78
| 25 mg
| BioXCell
| in vivo GRP78 blockade, in vitro GRP78 blockade, W
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BP0131-50MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0389-5MG
| InVivoMAb anti-canine CD34
| 5 mg
| BioXCell
| Immunohistochemistry (frozen), Flow cytometry, Wes
|
| Mouse
| Dog
| Solicitar Precio
| Solicitar
|
| BE0403-5MG
| InVivoMAb anti-mouse CD96
| 5 mg
| BioXCell
|
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0088-25MG
| InVivoPlus rat IgG1 isotype control, anti-horseradish peroxidase
| 25 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0401-5MG
| InVivoMAb anti-human CEACAM5
| 5 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0404-1MG
| InVivoMAb anti-human GPC3
| 1 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0301-100MG
| InVivoPlus human IgG2 isotype control
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0400-100MG
| InVivoMAb anti-mouse RGMb
| 100 mg
| BioXCell
| in vivo RGMb blockade, ELISA, Flow cytometry, ,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0017-1-5MG
| InVivoPlus anti-mouse CD40L (CD154)
| 5 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-50MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0004-1-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-5MG
| InVivoPlus polyclonal Armenian hamster IgG
| 5 mg
| BioXCell
|
|
| Armenian Hamster
|
| Solicitar Precio
| Solicitar
|
| BE0403-100MG
| InVivoMAb anti-mouse CD96
| 100 mg
| BioXCell
|
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0017-1-100MG
| InVivoPlus anti-mouse CD40L (CD154)
| 100 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0388-5MG
| InVivoMAb anti-human CD71 (TfR1)
| 5 mg
| BioXCell
| Immunohistochemistry (frozen)
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0401-25MG
| InVivoMAb anti-human CEACAM5
| 25 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0032-5MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-25MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0392-100MG
| InVivoMAb anti-mouse myeloperoxidase (MPO)
| 100 mg
| BioXCell
| in vivo administration, in vitro administration, I
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0273-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0394-100MG
| InVivoMAb anti-mouse IL-25
| 100 mg
| BioXCell
| in vivo IL-25 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0308-50MG
| InVivoPlus anti-rat CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0085-100MG
| InVivoPlus mouse IgG2a isotype control, unknown specificity
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0399-50MG
| InVivoMAb anti-mouse VEGF-A
| 50 mg
| BioXCell
| in vivo VEGF-A neutralization, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0032-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0399-25MG
| InVivoMAb anti-mouse VEGF-A
| 25 mg
| BioXCell
| in vivo VEGF-A neutralization, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-25MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 25 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0117-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0383-100MG
| InVivoMAb anti-mouse/human/rat PD-L1
| 100 mg
| BioXCell
| in vivo PD-L1 blockade
, in vitro PD-L1 blockade
,
|
| Mouse/Human/Rat
|
| Solicitar Precio
| Solicitar
|
| BP0274-25MG
| InVivoPlus anti-mouse TIGIT
| 25 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0079-50MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 50 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0075-25MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 25 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0391-100MG
| InVivoMAb anti-human MUC16
| 100 mg
| BioXCell
| Flow cytometry, Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0088-5MG
| InVivoPlus rat IgG1 isotype control, anti-horseradish peroxidase
| 5 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BP0307-25MG
| InVivoPlus anti-mouse CD16/CD32
| 25 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0396-100MG
| InVivoMAb anti-human/mouse GRP78
| 100 mg
| BioXCell
| in vivo GRP78 blockade, in vitro GRP78 blockade, W
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BP0115-25MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 25 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-5MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 5 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0329-5MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0085-25MG
| InVivoPlus mouse IgG2a isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0174-50MG
| InVivoPlus anti-mouse LAG-3
| 50 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0390-25MG
| InVivoMAb anti-canine PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Wester
|
| Dog
| Dog
| Solicitar Precio
| Solicitar
|
| BE0379-100MG
| InVivoMAb anti-mouse TSLP
| 100 mg
| BioXCell
| in vivo TSLP neutralization, in vitro TSLP neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0394-50MG
| InVivoMAb anti-mouse IL-25
| 50 mg
| BioXCell
| in vivo IL-25 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-25MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|